1.
Zhang X, Zhao L, Ngo LH, et al. Pre-diagnostic plasma proteomics profile for hepatocellular carcinoma. Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae079.
1.
Yin S, Klaeger S, Chea VA, et al. Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies. Frontiers in immunology. 2023;14:1269335. doi:10.3389/fimmu.2023.1269335.
1.
Truby LK, Maamari D, Saha A, et al. Towards Allograft Longevity: Leveraging Omics Technologies to Improve Heart Transplant Outcomes. Current heart failure reports. 2023;20(6):493-503. doi:10.1007/s11897-023-00631-z.
1.
Short MI, Fohner AE, Skjellegrind HK, et al. Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging. Journal of Alzheimer’s disease : JAD. 2023;96(4):1767-1780. doi:10.3233/JAD-230145.
1.
Stewart H, Lu Y, O’Keefe S, et al. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity. iScience. 2023;26(11):108080. doi:10.1016/j.isci.2023.108080.
1.
Shaban M, Bai Y, Qiu H, et al. MAPS: Pathologist-level cell type annotation from tissue images through machine learning. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.06.25.546474.
1.
Shaban M, Bai Y, Qiu H, et al. MAPS: Pathologist-level cell type annotation from tissue images through machine learning. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.06.25.546474.
1.
Schmidt N, Ganskih S, Wei Y, et al. SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. Cell. 2023. doi:10.1016/j.cell.2023.09.002.
1.
Bouhaddou M, Reuschl A-K, Polacco BJ, et al. SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell. 2023. doi:10.1016/j.cell.2023.08.026.
1.
Perry AS, Zhao S, Gajjar P, et al. Proteomic architecture of frailty across the spectrum of cardiovascular disease. Aging cell. 2023. doi:10.1111/acel.13978.